RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$926M
AUM Growth
+$212M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
99
New
Increased
Reduced
Closed

Top Buys

1
+$17.7M
2
+$9.4M
3
+$8.18M
4
XLRN
Acceleron Pharma
XLRN
+$8.1M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.8M

Top Sells

1
+$13.9M
2
+$9.07M
3
+$8.61M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$6.71M
5
NKTR icon
Nektar Therapeutics
NKTR
+$6.6M

Sector Composition

1 Healthcare 94.86%
2 Communication Services 1.03%
3 Energy 0.07%
4 Technology 0.06%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$14.8M 1.6%
155,000
+85,000
27
$14.7M 1.59%
227,000
-33,000
28
$14.4M 1.56%
410,000
-155,000
29
$13.3M 1.43%
210,778
-29,222
30
$12.7M 1.38%
75,000
-10,000
31
$12.4M 1.34%
167,680
-5,240
32
$12.2M 1.32%
475,000
-92,534
33
$12M 1.3%
130,780
34
$11.4M 1.23%
100,000
-30,000
35
$11.3M 1.23%
160,000
+64,000
36
$10.6M 1.14%
220,000
+30,000
37
$10.4M 1.13%
50,000
-5,000
38
$9.69M 1.05%
51,000
-18,000
39
$9.4M 1.02%
+125,000
40
$9.33M 1.01%
340,000
-25,000
41
$9.2M 0.99%
62,095
-17,905
42
$9.15M 0.99%
75,000
-55,000
43
$8.71M 0.94%
590,000
-130,000
44
$8.42M 0.91%
260,000
-40,325
45
$8.29M 0.9%
120,000
-51,000
46
$8.21M 0.89%
925,534
-74,466
47
$8.18M 0.88%
+95,000
48
$7.8M 0.84%
+12,500
49
$7.28M 0.79%
75,000
-15,000
50
$6.96M 0.75%
80,000
-24,300
1
2
3 4